Already a Bloomberg.com user?
Sign in with the same account.
Don't have an account?
Help! I can't access my account.
May 14 (Bloomberg) -- Robin Smith, chief executive officer
of NeoStem Inc., talks about the company's use of non-embryonic stem cells to create cell therapies.
She speaks with Pimm Fox on Bloomberg Television's "Taking Stock." (Source: Bloomberg)
On Air Now
Taking Stock with Pimm Fox
©2014 Bloomberg L.P. All Rights Reserved. Made in NYC